ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,852Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 599

$1.33M Total Retail Price of All Prescriptions

Rank: 4 out of 599

553 Patients Receiving at Least One Drug in Part D
23% Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Massachusetts
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

17% of this provider’s 553 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

6% of this provider’s 553 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 14%.

Prescription Price

$112 was the average price of a prescription from this provider, compared to $90 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
CLONAZEPAM 984 147 131 B 1 1
TRAZODONE HCL 555 110 97 2 2
LORAZEPAM 528 121 78 B 3 4
CYMBALTA 515 153 73 4 21
ALPRAZOLAM 494 77 63 B 5 12
SERTRALINE HCL 436 57 68 6 9
QUETIAPINE FUMARATE 416 53 63 A 7 3
LAMOTRIGINE 390 24 64 8 8
RISPERIDONE 371 71 51 A 9 5
CITALOPRAM HBR 365 121 60 10 7
AMPHETAMINE SALT COMBO 347 11 52 S2 11 26
BUPROPION HCL SR 330 69 47 12 14
ZOLPIDEM TARTRATE 324 20 47 13 18
BUPROPION XL 276 39 43 14 29
ABILIFY 224 <11 38 A 15 13
VENLAFAXINE HCL ER 220 92 28 16 19
ESCITALOPRAM OXALATE 219 84 33 17 32
BUSPIRONE HCL 197 26 34 18 25
OLANZAPINE 196 43 30 A 19 11
DIAZEPAM 196 36 31 B 19 27
DIVALPROEX SODIUM ER 190 <11 28 21 24
FLUOXETINE HCL 187 28 31 22 6
PAROXETINE HCL 184 32 29 23 23
SUBOXONE 183 0 22 S3 24 28
MIRTAZAPINE 182 41 31 25 16
BENZTROPINE MESYLATE 167 12 32 R 26 15
LATUDA 161 <11 24 A 27 57
LITHIUM CARBONATE 152 43 23 28 20
METHYLPHENIDATE HCL 140 24 22 S2 29 44
GABAPENTIN 139 32 32 30 17
OXCARBAZEPINE 125 <11 28 31 31
TOPIRAMATE 120 <11 22 32 34
BUPRENORPHINE-NALOXONE 114 0 20 S3 33 39
DEXTROAMPHETAMINE-AMPHETAMINE 96 11 15 S2 34 42
CLONIDINE HCL 94 <11 19 35 30
CLOZAPINE 92 <11 <11 A 36 10
AMITRIPTYLINE HCL 90 <11 11 R 37 41
ZIPRASIDONE HCL 78 0 12 A 38 35
DOXEPIN HCL 70 12 14 39 38
FLUVOXAMINE MALEATE 69 20 12 40 45
DIVALPROEX SODIUM 69 <11 <11 40 22
OXAZEPAM 67 <11 <11 B 42 84
ZOLPIDEM TARTRATE ER 67 <11 <11 42 77
INVEGA 65 <11 <11 A 44 58
LUNESTA 62 22 13 45 68
SEROQUEL XR 59 <11 <11 A 46 37
PERPHENAZINE 53 <11 <11 A 47 36
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.